Interesting Images

Avoid a New Coronavirus Lockdown

Subjects: Virology View times: 114
Submitted by: Camila Xu

Abstract

This topic of the first webinar of the COVID-19 series discussed how to avoid a new lockdown. The Chair of the online seminar, Prof. Dr. Antoine Flahault, explained how a second lockdown could be avoided in general, but also in the context of Europe. Professor Flahault then proceeded to answer questions from the audience.

The second guest speaker was Prof. Dr. Evelyne Bischof. As she was in China during the lockdown, she shared her hands-on experience with the audience and put forward different strategies in order to possibly avoid a second wave.

Antoine Flahault MD, PhD in biomathematics. He was appointed as full professor of public health in 2002. He was the founding director of the French School of Public Health (EHESP, Rennes, 2007-2012), co-director of Centre Virchow-Villermé for Public Health Paris-Berlin (Université Descartes, Sorbonne Paris Cité), co-director of the European Academic Global Health Alliance (EAGHA),and president of the Agency for Public Health Education Accreditation (APHEA). He conducted research in mathematical modelling of communicable diseases, chaired the WHO collaborative centre for electronic disease surveillance, and coordinated research on Chikungunya in Indian Ocean (Inserm Prize, 2006; was scientific curator of a large exhibition Epidemik, la Cité des Sciences et de l’Industrie (Paris, Rio and Sao Paulo)). In January 2014, he was appointed as professor of public health at School of Medicine, University of Geneva where he is the founding director of the Institute of Global Health. He was elected corresponding member at Académie Nationale de Médecine (Paris). In January 2014, he had more than 235 scientific publication referenced in Medline.

Evelyne Yehudit Bischof (Biskup), MD, MPH and Associate Professor at Shanghai University of Medicine and Health Sciences. Trained a.e. at Harvard Medical School affiliated hospitals (Mass General Hospital, Beth Israel MD, Dana Farber) and Columbia University NYC. Specialist in internal medicine, with research focus on Artificial Intelligence (AI) and digital health, especially in the fields of oncology, preventative and precision medicine, biogerontology, and geronto-oncology. Special interest in Gender medicine, chair of the IMAGINE group (Gender Group of the European Federation of Internal Medicine https://www.efim.org/working-groups/internal-medicine-assessment-gender-differences-europe-imagine ) and member of the Gender and COVID-19 Working Group. Published over 70 peer-reviewed papers, frequent speaker at scientific and medical conferences. Spent a decade practicing medicine, lecturing at medical schools and performing clinical and translational research in New York, Shanghai and Basel, with extensive experience in scientific research and clinical practice at the following well-known and highly reputable institutions: Fudan Cancer Institute and Hospital, Shanghai; Zhongshan Hospital (Fudan University), Renji Hospital (Jiaotong University) and Shanghai East Hospital (Tongji University). Based on education: working in medicine on an international and cross-cultural level, e.g. as a board member of the European Federation of Internal medicine, Swiss Society of Internal Medicine, and more. Motivation: “Instruction does much, but encouragement everything." J.W.v.Goethe.